$ONC (BeOne Medicines AG) — investor discussion on X

Five-factor rating: Hold (sector percentile 52.6%)

Graded daily on value C+, growth B, profitability A-, momentum B, revisions B. Sector-relative, identical for every user.

Most active credible voices on $ONC

@chitrader (CHItrader) — 2 mentions · 7.9K followers
@allday_stocks (alldaystocks) — 2 mentions · 6.0K followers
@hedgefundtips (Thomas J. Hayes) — 2 mentions · 72.4K followers

Recent headlines featuring $ONC

2026-09-01: Trump seals 9 pharma pricing deals, expanding MFN pact to 26 firms and 89% of branded drugs

Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $ONC are available with SpikePanel Pro.

Stock Ratings · Today Headlines · SpikePanel

For richer charts and full features, open SpikePanel on desktop.

$ONC — what investors on X are saying · SpikePanel

$ONCBeOne Medicines AG · Biotechnology · $45.0B

$420.92

-0.7%

Event thread

Key events, in time order

16 items

2026-11-06EarningsBull
BeOne Medicines Q3 Beats, Stock Hits 52-Week High
Q3 revenue/EPS beat; BRUKINSA US sales top $1B; FY guidance raised
D1 +5.1% · since +4.2%
2026-11-05Earnings
Earnings report
BRUKINSA第三季度全球销售额14亿美元，同比增长34%，美国销售额首次单季超过10亿美元，增长36%。
D1 +2.5% · since +9.5%

14 earlier events

2026-10-27Insider selling
Insider selling $11.3M (1)
D1 -1.3% · +5d -3.0%
2026-10-13Insider selling
Insider selling $10.9M (1)
D1 -0.4% · +5d +10.1%
2026-10-01AnalystBull
17 Firms Rate ONC Buy, Consensus Target $402.71
Broad analyst consensus signals positive market outlook for BeOne Medicines
D1 -2.0% · +5d -2.4%
2026-09-28Insider selling
Insider selling $11.3M (1)
D1 +1.7% · +5d -1.5%
2026-09-08Insider selling
Insider selling $13.4M (1)
D1 -1.9% · +5d -1.4%
2026-09-01Company
BeOne Medicines Reaches Drug Access Agreement with U.S. Government
Voluntary agreement expands access to innovative cancer drugs; mentioned by Trump
D1 -0.3% · +5d -2.1%
2026-08-12Insider selling
Insider selling $19.7M (1)
D1 -0.1% · +5d +5.0%
2026-08-11Insider selling
Insider selling $26.6M (2)
D1 +0.1% · +5d +2.8%
2026-08-10Insider selling
Insider selling $41.2M (1)
D1 +3.1% · +5d +1.0%
2026-08-05Earnings
Earnings report
D1 +1.4% · +5d +9.6%
2026-07-21Insider selling
Insider selling $19.5M (1)
D1 +2.6% · +5d +3.7%
2026-07-20Insider selling
Insider selling $15.1M (1)
D1 -0.5% · +5d +4.9%
2026-07-17Insider selling
Insider selling $20.2M (1)
D1 -1.7% · +5d +4.4%
2026-07-16Insider selling
Insider selling $53.0M (1)
D1 +2.0% · +5d +2.9%

①

Bull vs bear

by direction · sourced

Bull signals0

None yet

Bear signals0

None yet

Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice

⑩

Discussion

be the first

Be civil · your views are your own

No comments yet.

Facts and opinions separated · All items sourced · Not investment advice

Event thread

Key events, in time order

16 items

2026-11-06EarningsBull
BeOne Medicines Q3 Beats, Stock Hits 52-Week High
Q3 revenue/EPS beat; BRUKINSA US sales top $1B; FY guidance raised
D1 +5.1% · since +4.2%
2026-11-05Earnings
Earnings report
BRUKINSA第三季度全球销售额14亿美元，同比增长34%，美国销售额首次单季超过10亿美元，增长36%。
D1 +2.5% · since +9.5%
2026-10-27Insider selling
Insider selling $11.3M (1)
D1 -1.3% · +5d -3.0%
2026-10-13Insider selling
Insider selling $10.9M (1)
D1 -0.4% · +5d +10.1%
2026-10-01AnalystBull
17 Firms Rate ONC Buy, Consensus Target $402.71
Broad analyst consensus signals positive market outlook for BeOne Medicines
D1 -2.0% · +5d -2.4%

11 earlier events

2026-09-28Insider selling
Insider selling $11.3M (1)
D1 +1.7% · +5d -1.5%
2026-09-08Insider selling
Insider selling $13.4M (1)
D1 -1.9% · +5d -1.4%
2026-09-01Company
BeOne Medicines Reaches Drug Access Agreement with U.S. Government
Voluntary agreement expands access to innovative cancer drugs; mentioned by Trump
D1 -0.3% · +5d -2.1%
2026-08-12Insider selling
Insider selling $19.7M (1)
D1 -0.1% · +5d +5.0%
2026-08-11Insider selling
Insider selling $26.6M (2)
D1 +0.1% · +5d +2.8%
2026-08-10Insider selling
Insider selling $41.2M (1)
D1 +3.1% · +5d +1.0%
2026-08-05Earnings
Earnings report
D1 +1.4% · +5d +9.6%
2026-07-21Insider selling
Insider selling $19.5M (1)
D1 +2.6% · +5d +3.7%
2026-07-20Insider selling
Insider selling $15.1M (1)
D1 -0.5% · +5d +4.9%
2026-07-17Insider selling
Insider selling $20.2M (1)
D1 -1.7% · +5d +4.4%
2026-07-16Insider selling
Insider selling $53.0M (1)
D1 +2.0% · +5d +2.9%

$ONC (BeOne Medicines AG) — investor discussion on X

Five-factor rating: Hold (sector percentile 52.6%)

Most active credible voices on $ONC

Recent headlines featuring $ONC

$ONC (BeOne Medicines AG) — investor discussion on X

Five-factor rating: Hold (sector percentile 52.6%)

Most active credible voices on $ONC

Recent headlines featuring $ONC

BeOne Medicines Q3 Beats, Stock Hits 52-Week High

Earnings report

Insider selling $11.3M (1)

Insider selling $10.9M (1)

17 Firms Rate ONC Buy, Consensus Target $402.71

Insider selling $11.3M (1)

Insider selling $13.4M (1)

BeOne Medicines Reaches Drug Access Agreement with U.S. Government

Insider selling $19.7M (1)

Insider selling $26.6M (2)

Insider selling $41.2M (1)

Earnings report

Insider selling $19.5M (1)

Insider selling $15.1M (1)

Insider selling $20.2M (1)

Insider selling $53.0M (1)

Bull vs bear

Discussion

BeOne Medicines Q3 Beats, Stock Hits 52-Week High

Earnings report

Insider selling $11.3M (1)

Insider selling $10.9M (1)

17 Firms Rate ONC Buy, Consensus Target $402.71

Insider selling $11.3M (1)

Insider selling $13.4M (1)

BeOne Medicines Reaches Drug Access Agreement with U.S. Government

Insider selling $19.7M (1)

Insider selling $26.6M (2)

Insider selling $41.2M (1)

Earnings report

Insider selling $19.5M (1)

Insider selling $15.1M (1)

Insider selling $20.2M (1)

Insider selling $53.0M (1)